AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
Titel:
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
Auteur:
Moradi Manesh, Donya El-Hoss, Jad Evans, Kathryn Richmond, Jennifer Toscan, Cara E. Bracken, Lauryn S. Hedrick, Ashlee Sutton, Rosemary Marshall, Glenn M. Wilson, William R. Kurmasheva, Raushan T. Billups, Catherine Houghton, Peter J. Smith, Malcolm A. Carol, Hernan Lock, Richard B.